Skip to main content
. Author manuscript; available in PMC: 2009 Sep 4.
Published in final edited form as: J Biopharm Stat. 2008;18(6):1063–1083. doi: 10.1080/10543400802369004

Table 3. Population-Average and Subject-Specific AUCR Prediction.

Ki Dose/Combination (KETO/MDZ)mg Population-Average AUCR Subject-Specific AUCR Between-Subject/Study CV
0.0037 200/2 3.02 ×/÷ 1.112 2.94 ×/÷ 1.258 0.242×/÷ 1.090
0.01 200/2 2.43 ×/÷ 1.084 2.35 ×/÷ 1.222 0.217×/÷ 1.116
0.18 200/2 1.21 ×/÷ 1.014 1.19 ×/÷ 1.085 0.084×/÷ 1.078
0.0037 400/5 3.72 ×/÷ 1.130 3.50 ×/÷ 1.273 0.254×/÷ 1.116
0.01 400/5 3.17 ×/÷ 1.108 2.94 ×/÷ 1.255 0.234×/÷ 1.091
0.18 400/5 1.45 ×/÷ 1.020 1.39 ×/÷ 1.124 0.120×/÷ 1.066
0.0037 800/10 3.93 ×/÷ 1.139 3.61 ×/÷ 1.280 0.249×/÷ 1.155
0.01 800/10 3.56 ×/÷ 1.119 3.34 ×/÷ 1.260 0.224×/÷ 1.139
0.18 800/10 1.78 ×/÷ 1.028 1.69 ×/÷ 1.153 0.151×/÷ 1.058

Note: the results are presented as mean×/÷ (1+CV)*100%.